Concepedia

Federica Capozzi

FC

8

Publications

657

Citations

8

H-Index

1983

Active since

Affiliations

University of Turin(Current)

Candiolo Cancer Institute

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Ortopedico Rizzoli

Polytechnic University of Turin

Federica Capozzi is an author at University of Turin specializing in cancer therapeutics, radiation oncology, and cancer research.

ORCID

Top concepts

Publications per year

1983–2022

8

Publications

8

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial

Giovanni Grignani, Emanuela Palmerini, Virginia Ferraresi et al. · The Lancet Oncology · 2014 · 328 citations · Full text

, , +6

The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models

Ymera Pignochino, Carmine Dell’Aglio, Marco Basiricò et al. · Clinical Cancer Research · 2013 · 107 citations

PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models

Ymera Pignochino, Federica Capozzi, Lorenzo D’Ambrosio et al. · Molecular Cancer · 2017 · 69 citations · Full text

Carcinoidal lumor of the Kidney

Frederick G. Zak, K Jindrák, Federica Capozzi · Ultrastructural Pathology · 1983 · 44 citations

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

Ymera Pignochino, Carmine Dell’Aglio, Simona Inghilleri et al. · BMC Cancer · 2015 · 34 citations · Full text

Rows per page

1–5 of 8